No abstract available
Keywords:
Enzyme replacement therapy; Hunter syndrome; Maroteaux–Lamy syndrome; Mucopolysaccharidosis type II; Mucopolysacchridosis type VI.
MeSH terms
-
Adolescent
-
Child
-
Disease Progression
-
Drug Administration Schedule
-
Enzyme Replacement Therapy
-
Europe, Eastern
-
Female
-
Humans
-
Injections, Intravenous
-
Male
-
Mucopolysaccharidoses / pathology
-
Mucopolysaccharidoses / therapy*
-
N-Acetylgalactosamine-4-Sulfatase / therapeutic use*
-
Recombinant Proteins / therapeutic use
-
Withholding Treatment / economics
-
Withholding Treatment / ethics*
Substances
-
Recombinant Proteins
-
N-Acetylgalactosamine-4-Sulfatase
-
galsulfase